EVO - CIK 0001412558
Evotec SE trades as EVO and has a market capitalization of $464.89 M, making it the #2673 largest US-listed company by market value. This page tracks Evotec SE through 180 SEC filings, with financial statements and metrics updated as new reports are filed.
| Filing | Type | Filed |
|---|---|---|
| 6-K | - | 2026-05-06 |
| SCHEDULE 13D/A | - | 2026-05-01 |
| 6-K | - | 2026-04-30 |
| 6-K | - | 2026-04-24 |
| 6-K | - | 2026-04-08 |
| 20-F | - | 2026-04-08 |
| 6-K | - | 2026-04-07 |
| SCHEDULE 13D/A | - | 2026-04-06 |
It is a prime concern of Evotec that all relevant target groups receive the same information at the same time. This implies communicating in both English and German.
Evotec gibt Ergebnisse für das erste Quartal 2026 bekannt: Transformation gewinnt an Dynamik - Evotec
Evotec Announces ‘Horizon’ – Next Inflection in Its Strategic Transformation to Accelerate Growth and Promote Agility
The largest companies sharing Evotec SE's SEC industry classification (pharmaceutical preparations).
Evotec SE (EVO) has a market capitalization of $464.89 M as of 2026-06-10, ranking #2673 among US-listed companies.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.